Skin substitute‐assisted repair shows reduced dermal fibrosis in acute human wounds validated simultaneously by histology and optical coherence tomography
Open Access
- 31 July 2015
- journal article
- research article
- Published by Wiley in Wound Repair and Regeneration
- Vol. 23 (4) , 483-494
Abstract
Skin substitutes are heterogeneous biomaterials designed to accelerate wound healing through provision of replacement extracellular matrix. Despite growing evidence for their use in chronic wounds, the role of skin substitutes in acute wound management and their influence on fibrogenesis remains unclear. Skin substitute characteristics including biocompatibility, porosity, and elasticity strongly influence cellular behavior during wound healing. Thus, we hypothesize that structural and biomechanical variation between biomaterials may induce differential scar formation after cutaneous injury. The following human prospective cohort study was designed to investigate this premise. Four 5‐mm full thickness punch biopsies were harvested from 50 volunteers. In all cases, site 1 healed by secondary intention, site 2 was treated with collagen‐GAG scaffold (CG), and decellularised dermis (DCD) was applied to site 3 while tissue extracted from site 4 was replaced (autograft). Healing tissue was assessed weekly with optical coherence tomography (OCT), before being excised on days 7, 14, 21, or 28 depending on study group allocation for later histological and immunohistochemical evaluation. Extracted RNA was used in microarray analysis and polymerase chain reaction of highlighted genes. Autograft treatment resulted in minimal fibrosis confirmed immunohistochemically and with OCT through significantly lower collagen I levels (p = 0.047 and 0.03) and reduced mean grayscale values (p = 0.038 and 0.015), respectively. DCD developed intermediate scar formation with partial rete ridge reformation and reduced fasiculonodular fibrosis. It was uniquely associated with late up‐regulation of matrix metalloproteinases 1 and 3, oncostatin M, and interleukin‐10 (p = 0.007, 0.04, 0.019, 0.019). Regenerated dermis was significantly thicker in DCD and autografts 28 days post‐injury compared with control and CG samples (p = 0.003 and <0.0001). In conclusion, variable fibrotic outcomes were observed in skin substitute‐treated wounds with reduced scarring in autograft and DCD samples compared with controls. OCT enabled concurrent assessment of wound morphology and quantification of dermal fibrosis.Keywords
Funding Information
- Tissue Regenix Ltd (York, UK)
This publication has 42 references indexed in Scilit:
- Scarless Fetal Wound Healing: A Basic Science ReviewPlastic and Reconstructive Surgery, 2010
- Inflammation in Wound Repair: Molecular and Cellular MechanismsJournal of Investigative Dermatology, 2007
- Acute downregulation of connexin43 at wound sites leads to a reduced inflammatory response, enhanced keratinocyte proliferation and wound fibroblast migrationJournal of Cell Science, 2006
- Tissue engineering of replacement skin: the crossroads of biomaterials, wound healing, embryonic development, stem cells and regenerationJournal of The Royal Society Interface, 2006
- Of Extracellular Matrix, Scaffolds, and Signaling: Tissue Architecture Regulates Development, Homeostasis, and CancerAnnual Review of Cell and Developmental Biology, 2006
- Matrix metalloproteinase 9 (MMP-9) is upregulated during scarless wound healing in athymic nude miceMatrix Biology, 2006
- Scarless skin repair in immunodeficient miceWound Repair and Regeneration, 2006
- Wound healing: an overview of acute, fibrotic and delayed healingFrontiers in Bioscience-Landmark, 2004
- Wound Healing in the PU.1 Null Mouse—Tissue Repair Is Not Dependent on Inflammatory CellsCurrent Biology, 2003
- Skin scarringBMJ, 2003